Contact Us marketing@medicilon.com
CN
×
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button

ContainchemistryContent

Dec 17,2020
Analysis on the Application of Enzyme Catalysis Technology in Green Chemistry
Enzyme catalyst catalysis has the characteristics of mild reaction conditions, high regioselectivity and high stereoselectivity.
More
Analysis on the Application of Enzyme Catalysis Technology in Green Chemistry
Dec 17,2020
Biocatalysis Technology to Improve Atomic Economy
Biocatalysis technology has accelerated the development of green chemistry technology and is one of the important trends in the development of green chemistry and green chemical engineering.
More
Biocatalysis Technology to Improve Atomic Economy
Dec 15,2020
Green Chemistry Technology: Photoredox Reaction
Medicilon has been vigorously developing new technologies over the years, integrating emerging methods of green chemistry into its services to customers, using currently popular green enzyme chemistry, photo-redox catalysts, continuous reactions, etc.
More
Green Chemistry Technology: Photoredox Reaction
Dec 09,2020
The Role of Dynamic Combinatorial Chemistry in the Discovery of Lead Compounds
Dynamic combinatorial chemistry is a new research method developed on the basis of combinatorial chemistry using the characteristics of supramolecular chemistry. Discovery of lead compounds and optimization of lead compounds are critical to medical research and development.
More
The Role of Dynamic Combinatorial Chemistry in the Discovery of Lead Compounds
Nov 23,2020
The details of pathological research determine the success or failure of TCR trials
What is the core technology of the TCR test? Immunohistochemistry technology (IHC, immunohistochemistry). Using frozen or fixed tissue specimens, sectioning, and staining the tissues in situ by antigen-antibody reaction and histochemical color reaction in the tissue cells with specific antibodies labeled with chromogenic reagents, and qualitatively, localizing, and quantitatively determining the corresponding antigens A technology.
More
The details of pathological research determine the success or failure of TCR trials
Oct 31,2020
ABM Therapeutics presented Medicilon with a commemorative trophy of "our first candidate compound"
On October 31, 2020, ABM Therapeutics awarded the "Our First Candidate Compound" commemorative trophy to Dr. Li Zhigang, Vice President of Research and Development of Medicilon Chemistry Department, to thank Medicilon for its FTE form of cooperation, the pharmaceutical and chemical team helped it discover and advance the first drug candidate ABM-1310 to enter the clinical phase I in the United States.
More
ABM Therapeutics presented Medicilon with a commemorative trophy of "our first candidate compound"
Oct 31,2020
ABM Therapeutics presented Medicilon with a commemorative trophy of "our first candidate compound"
On October 31, 2020, ABM Therapeutics awarded the "Our First Candidate Compound" commemorative trophy to Dr. Li Zhigang, Vice President of Research and Development of Medicilon Chemistry Department, to thank Medicilon for its FTE form of cooperation, the pharmaceutical and chemical team helped it discover and advance the first drug candidate ABM-1310 to enter the clinical phase I in the United States.
More
ABM Therapeutics presented Medicilon with a commemorative trophy of "our first candidate compound"
Oct 19,2020
Medicilon-Phenomenex Chiral Segmentation Joint Laboratory Unveiling Ceremony
Shanghai, China, October 15, 2020-Shanghai Medicilon and Phenomenex reached a strategic agreement to jointly build a chemistry laboratory for chiral interchange and further enhance the scientific research of Medicilon's drug discovery platform, helping more customers with new drug research.
More
Medicilon-Phenomenex Chiral Segmentation Joint Laboratory Unveiling Ceremony
Oct 14,2020
High-throughput ADME research in the new drug discovery phase
During the drug discovery stage, ADME research is faced with the problem of a large variety of compounds to be tested (due to the development of combinatorial chemistry and parallel synthesis technology),
More
High-throughput ADME research in the new drug discovery phase
Jul 13,2020
Chemical FTE Service
Medicilon provides customers with chemical FTE services including medicinal chemistry, compound library design and synthesis, synthetic chemistry, and synthetic process development.
More
Chemical FTE Service
Jun 19,2020
Proteomics Technical Service
Medicilon's proteomics technology service integrates multiple technologies such as biochemistry, cell biology, molecular biology, and mass spectrometry to enable protein identification, differential protein quantitative analysis, complex separation, and protein post-translational modification (eg, phosphorylation) , Glycosylation, ubiquitination, etc.) analysis and proteomics informatics analysis.
More
Proteomics Technical Service
Jun 18,2020
Bio-Plex suspension chip multiple detection platform
Medicilon Biology has extensive and extensive experience in the field of in vitro biology. Medicilon measures enzyme levels, cell levels, cell biology, biochemistry, in vitro isotope measurements, stable cell line establishment, gene knockout, RNAi And MicroRNA technology, etc., can provide a complete set of biological services.
More
Bio-Plex suspension chip multiple detection platform
Jun 17,2020
Medicilon Enzyme Activity Testing Service
The biological department of Shanghai Medicilon has extensive experience in the field of in vitro biology, through enzyme level measurement, cell level measurement, cell biology, biochemistry, in vitro isotope measurement, stable cell line establishment, gene knockout, RNAi and MicroRNA Technology, etc., to provide a complete set of biological services.
More
Medicilon Enzyme Activity Testing Service
Jun 16,2020
Medicilon ion channel screening service
Under the leadership of experienced medicinal chemistry leaders, Medicilon provides customers with new drug development services covering a variety of targets and diseases, including from active compound discovery, target verification, lead compound optimization to the selection of preclinical drug candidates.
More
Medicilon ion channel screening service
Jun 15,2020
In situ hybridization technology-Shanghai Medicilon
In situ hybridization (insituhybridization) uses a specific labeled nucleic acid of known base sequence as a probe to specifically detect the nucleic acid in tissues and cells in accordance with the principle of complementary base pairing in situ to form a hybrid, which is then labeled with The corresponding monitoring system of the substance can locate the nucleic acid in the cell in situ by immunohistochemistry.
More
In situ hybridization technology-Shanghai Medicilon
Jun 11,2020
Medicilon Drug Impurity Analysis Service
Medicilon's analytical chemistry and purification separation team provides customers with high-quality drug Impurity analysis service.
More
Medicilon Drug Impurity Analysis Service
Jun 11,2020
Immunohistochemical staining (immunohistochemistry)
Immunohistochemistry is a technique for detecting peptides and proteins in tissues based on the principle of specific binding of antigens and antibodies. Medicilon can provide frozen section, special staining, immunohistochemical staining, TCR.
More
Immunohistochemical staining (immunohistochemistry)
Apr 25,2020
Medicilon's Pharmacology Research
Medicilon's Technology Department aims to meet customers' one-stop service needs for API R&D, utilize rich medicinal chemistry experience to efficiently promote customers' drug R&D projects, promote new drug processes into new drug clinical research earlier, and effectively help customers Control the cost of new drug development.
More
Mar 11,2020
Medicilon Drug Discovery - Chemistry Department
The Medicilon Chemistry Department is a professional, efficient, and well-qualified R&D team. The team has more than 40% of employees with a master's degree, doctor's degree, or above.
More
Medicilon Drug Discovery - Chemistry Department
Sep 11,2019
Dr. Ma Jianguo: Adding "Green" to API Synthesis
I think the core concept of green chemistry is mainly reflected in three points: the first is security, the second is to reduce the "three wastes," and the third is to reduce costs. For more detailed explanations of green chemistry, refer to the "12 principles of green chemistry". This principle has explained a clear interpretation of the concepts and applications of green chemistry.
More
Dr. Ma Jianguo: Adding "Green" to API Synthesis